Alexander Nowak
Stock Analyst at Craig-Hallum
(2.73)
# 2,137
Out of 5,106 analysts
46
Total ratings
45.95%
Success rate
7.31%
Average return
Main Sectors:
Stocks Rated by Alexander Nowak
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CELC Celcuity | Maintains: Buy | $96 → $108 | $105.25 | +2.61% | 3 | Nov 13, 2025 | |
| CVRX CVRx, Inc. | Maintains: Buy | $20 → $22 | $8.44 | +160.66% | 5 | Jan 17, 2025 | |
| NTRA Natera | Maintains: Buy | $121 → $157 | $231.95 | -32.31% | 4 | Nov 13, 2024 | |
| BVS Bioventus | Maintains: Buy | $12 → $17 | $7.56 | +125.02% | 6 | Sep 27, 2024 | |
| QDEL QuidelOrtho | Upgrades: Buy | $40 → $57 | $28.80 | +97.92% | 6 | Sep 5, 2024 | |
| CDNA CareDx | Upgrades: Buy | $12 → $15 | $20.56 | -27.04% | 3 | May 1, 2024 | |
| DMAC DiaMedica Therapeutics | Assumes: Buy | $8 | $9.39 | -14.80% | 4 | Apr 24, 2024 | |
| LUNG Pulmonx | Initiates: Buy | $18 | $2.53 | +611.46% | 1 | Sep 5, 2023 | |
| TNDM Tandem Diabetes Care | Maintains: Buy | $74 → $50 | $21.39 | +133.75% | 2 | Jun 13, 2023 | |
| DRIO DarioHealth | Maintains: Buy | $280 → $160 | $11.89 | +1,245.67% | 1 | May 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $101.50 | - | 1 | Oct 19, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $0.66 | - | 2 | Mar 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $11 | $2.37 | +364.14% | 1 | Jan 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $88 → $110 | $58.51 | +88.00% | 3 | Feb 3, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sell | n/a | $6.85 | - | 2 | Jan 20, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $300 | $2.07 | +14,392.75% | 1 | Jan 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $28 | $9.24 | +203.03% | 1 | Aug 31, 2020 |
Celcuity
Nov 13, 2025
Maintains: Buy
Price Target: $96 → $108
Current: $105.25
Upside: +2.61%
CVRx, Inc.
Jan 17, 2025
Maintains: Buy
Price Target: $20 → $22
Current: $8.44
Upside: +160.66%
Natera
Nov 13, 2024
Maintains: Buy
Price Target: $121 → $157
Current: $231.95
Upside: -32.31%
Bioventus
Sep 27, 2024
Maintains: Buy
Price Target: $12 → $17
Current: $7.56
Upside: +125.02%
QuidelOrtho
Sep 5, 2024
Upgrades: Buy
Price Target: $40 → $57
Current: $28.80
Upside: +97.92%
CareDx
May 1, 2024
Upgrades: Buy
Price Target: $12 → $15
Current: $20.56
Upside: -27.04%
DiaMedica Therapeutics
Apr 24, 2024
Assumes: Buy
Price Target: $8
Current: $9.39
Upside: -14.80%
Pulmonx
Sep 5, 2023
Initiates: Buy
Price Target: $18
Current: $2.53
Upside: +611.46%
Tandem Diabetes Care
Jun 13, 2023
Maintains: Buy
Price Target: $74 → $50
Current: $21.39
Upside: +133.75%
DarioHealth
May 12, 2023
Maintains: Buy
Price Target: $280 → $160
Current: $11.89
Upside: +1,245.67%
Oct 19, 2022
Downgrades: Hold
Price Target: n/a
Current: $101.50
Upside: -
Mar 28, 2022
Downgrades: Hold
Price Target: n/a
Current: $0.66
Upside: -
Jan 5, 2022
Initiates: Buy
Price Target: $11
Current: $2.37
Upside: +364.14%
Feb 3, 2021
Maintains: Buy
Price Target: $88 → $110
Current: $58.51
Upside: +88.00%
Jan 20, 2021
Downgrades: Sell
Price Target: n/a
Current: $6.85
Upside: -
Jan 11, 2021
Initiates: Buy
Price Target: $300
Current: $2.07
Upside: +14,392.75%
Aug 31, 2020
Initiates: Buy
Price Target: $28
Current: $9.24
Upside: +203.03%